Anita Jain - Apr 3, 2023 Form 3 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: 10%+ Owner
Signature: /s/Anita Jain
Stock symbol: BTAI
Transactions as of: Apr 3, 2023
Transactions value $: $0
Form type: 3
Date filed: 4/13/2023, 07:08 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BTAI	Common Stock, par value $0.001 per share						550	Apr 3, 2023	Direct
holding	BTAI	Common Stock, par value $0.001 per share						8.55M	Apr 3, 2023	By BioXcel LLC

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person may be deemed to share investment control over shares of Common Stock of the Issuer held by BioXcel LLC and held indirectly by BioXcel Holdings, Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent, if any, of the reporting person's pecuniary interest therein, and this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act or otherwise, the beneficial owner of any such shares of Common Stock.